154 related articles for article (PubMed ID: 627380)
1. [Oral contraceptives, hypertension and nephrosclerosis].
Girndt J
Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
[TBL] [Abstract][Full Text] [Related]
2. [The pathogenesis of oral contraceptive hypertension (author's transl)].
Girndt J; Scheler F
Klin Wochenschr; 1977 Apr; 55(7):347-8. PubMed ID: 870746
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
4. [Clinical course and pathogenesis of oral contraceptive hypertension (author's transl)].
Girndt J; Scheler F
Med Klin; 1977 Oct; 72(41):1680-4. PubMed ID: 916953
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Saruta T; Nakamura R; Nagahama S; Suzuki H; Kondo K
Gynecol Obstet Invest; 1981; 12(1):11-20. PubMed ID: 7019015
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects of hypertension under contraceptive steroids].
Kaulhausen H; Klingsiek L
Fortschr Med; 1976 Dec; 94(34):2005-13. PubMed ID: 793966
[TBL] [Abstract][Full Text] [Related]
9. Oestrogens and hypertension.
Roberts JM
Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
[TBL] [Abstract][Full Text] [Related]
10. An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
Shionoiri H; Eggena P; Barrett JD; Thananopavarn C; Golub MS; Eggena Z; Nakamura R; Judd HL; Sambhi MP
Biochem Med; 1983 Feb; 29(1):14-22. PubMed ID: 6838497
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
12. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
Weinberger MH; Kramer NJ; Grim CE; Petersen LP
J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
[TBL] [Abstract][Full Text] [Related]
13. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Weir RJ
Scott Med J; 1982 Jul; 27(3):212-5. PubMed ID: 6810459
[TBL] [Abstract][Full Text] [Related]
14. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
[TBL] [Abstract][Full Text] [Related]
15. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
Hollenberg NK; Williams GH; Burger B; Chenitz W; Hoosmand I; Adams DF
Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy.
Thadhani R; Stampfer MJ; Chasan-Taber L; Willett WC; Curhan GC
Contraception; 1999 Sep; 60(3):145-50. PubMed ID: 10640157
[TBL] [Abstract][Full Text] [Related]
17. [Oral contraceptives and arterial hypertension].
Pinheiro RL; da Costa JN
Rev Port Cardiol; 1988; 7(3):333-43. PubMed ID: 3078732
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.
Oelkers WK
Steroids; 1996 Apr; 61(4):166-71. PubMed ID: 8732994
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.
De Leo V; la Marca A; Morgante G; Lucani B; Nami R; Ciotta L; Cianci A; Petraglia F
Contraception; 2001 Sep; 64(3):145-8. PubMed ID: 11704092
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraceptives and hypertension].
Werning C; Siegenthaler W
Schweiz Med Wochenschr; 1971 Apr; 101(15):543-4. PubMed ID: 4325189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
